BioSens8

BioSens8 is a deeptech company that develops continuous and non-invasive biosensor technology for personalized health monitoring. By mining microbes, the company engineers biosensors designed to provide quantitative, real-time insights into a body's physiological state. Their platform technology aims to move beyond traditional point-in-time testing by creating multiplexed wearable devices that can monitor hormones, neurotransmitters, and drug levels. The company, which spun out of Boston University in 2020 and is based at The Engine in Cambridge, Massachusetts, integrates bioengineering with hardware development to create medical-grade monitors that can display data directly through mobile applications.

This technology is primarily designed to enable proactive, data-driven healthcare and personalized medicine. A core application of their work is the MySensing device, an at-home hormone monitoring system intended to support individuals undergoing IVF by providing continuous, blood-based tracking to improve timing and success rates. By offering an affordable, portable, and easy-to-use alternative to frequent clinical visits, BioSens8 seeks to reduce the stress and logistical burden associated with fertility monitoring and other chronic health management tasks. The company’s work is supported by various grants and awards, reflecting its focus on developing innovative solutions for complex health challenges.